Aspirin Inhibits Metastatic Cancer Spread, Reducing Mortality by 21 Percent: Study

A comprehensive review found that patients who take aspirin have a relatively lower risk of developing various types of cancer.
Aspirin Inhibits Metastatic Cancer Spread, Reducing Mortality by 21 Percent: Study
Freepik
|Updated:
0:00

Aspirin is a long-established and widely used medication with a long history. In addition to its well-known uses for pain relief and its anti-inflammatory and anticoagulant properties, a recent study indicates that cancer patients who take low-dose aspirin daily experience a 21 percent reduction in mortality.

There’s also evidence of aspirin’s role in preventing cancer metastasis.

Ellen Wan
Ellen Wan
Author
Ellen Wan has worked for the Japanese edition of The Epoch Times since 2007.
Related Topics